サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：骨髄移植の世界市場－成長、将来展望、競合分析（2022年～2030年）
市場調査レポート
商品コード
1149164

骨髄移植の世界市場－成長、将来展望、競合分析（2022年～2030年）

Bone Marrow Transplantation Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日: | 発行: Acute Market Reports | ページ情報: 英文 116 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
骨髄移植の世界市場－成長、将来展望、競合分析（2022年～2030年）
出版日: 2022年08月16日
発行: Acute Market Reports
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の骨髄移植の市場規模は、2022年から2030年の予測期間中に5.9％のCAGRで成長すると予想されています。健康なドナーの数の増加、病気の再発リスクが低いこと、幹細胞バンクの増加、慢性リンパ性白血病の有病率の上昇は、骨髄移植市場の成長を牽引しています。

当レポートでは、世界の骨髄移植市場について調査分析し、ビジネス展望、市場力学、市場分析、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 序文

  • レポートの説明
    • レポートの目的
    • 対象者
    • 主な製品
  • 市場セグメンテーション
  • 調査手法
    • フェーズⅠ－2次調査
    • フェーズⅡ－1次調査
    • フェーズⅢ－専門家による審査
    • 仮定
    • 採用されたアプローチ

第2章 エグゼクティブサマリー

  • 市場スナップショット：世界の骨髄移植市場
  • 世界の骨髄移植市場（100万米ドル）（2021年）：タイプ別
  • 世界の骨髄移植市場（100万米ドル）（2021年）：適応症別
  • 世界の骨髄移植市場（100万米ドル）：地域別
  • COVID-19の影響
  • 魅力的な投資提案（2021年）：地域別
  • 競合分析
    • 主要な骨髄移植市場ベンダーの市場ポジショニング
    • 骨髄移植市場のベンダーが採用する戦略
    • 主要な業界戦略

第3章 骨髄移植市場：ビジネス展望と市場力学

  • イントロダクション
  • 世界の骨髄移植市場金額（100万米ドル）（2020年～2030年）
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析
  • ポーターのファイブフォースモデル
    • サプライヤーの力
    • バイヤーの力
    • 代替品の脅威
    • 新規参入業者の脅威
    • 競争企業間の敵対関係
  • PESTEL分析
    • 政治的
    • 経済的
    • 技術的
    • 法的
    • 社会的

第4章 骨髄移植市場、米ドル（100万）（2020年～2030年）：タイプ別

  • 市場概要
  • 成長と収益分析：2021年と2030年の比較
  • 市場セグメンテーション
    • 同種骨髄移植
    • 自家骨髄移植

第5章 骨髄移植市場、米ドル（100万）（2020年～2030年）：適応症別

  • 市場概要
  • 成長と収益分析：2021年と2030年の比較
  • 市場セグメンテーション
    • 白血病
    • リンパ腫
    • 骨髄腫
    • その他

第6章 北米の骨髄移植市場、米ドル（100万）（2020年～2030年）

第7章 英国および欧州連合の骨髄移植市場、米ドル（100万）（2020年～2030年）

第8章 アジア太平洋の骨髄移植市場、米ドル（100万）（2020年～2030年）

第9章 ラテンアメリカの骨髄移植市場、米ドル（100万）（2020年～2030年）

第10章 中東およびアフリカの骨髄移植市場、米ドル（100万）（2020年～2030年）

第11章 企業プロファイル

  • AllCells LLC
  • Conversant Bio
  • Cellular Dynamics International
  • Gamida Cell Ltd.
  • Hemacare Corporation
  • Lonza Group Ltd.
  • Merck Millipore Corporation
  • Mesoblast Ltd
  • PromoCell GmbH
  • STEMCELL Technologies
図表

List of Tables

  • TABLE 1 Global Bone Marrow Transplantation Market By Type, 2020-2030, USD (Million)
  • TABLE 2 Global Bone Marrow Transplantation Market By Indication, 2020-2030, USD (Million)
  • TABLE 3 North America Bone Marrow Transplantation Market By Type, 2020-2030, USD (Million)
  • TABLE 4 North America Bone Marrow Transplantation Market By Indication, 2020-2030, USD (Million)
  • TABLE 5 UK and European Union Bone Marrow Transplantation Market By Type, 2020-2030, USD (Million)
  • TABLE 6 UK and European Union Bone Marrow Transplantation Market By Indication, 2020-2030, USD (Million)
  • TABLE 7 Asia Pacific Bone Marrow Transplantation Market By Type, 2020-2030, USD (Million)
  • TABLE 8 Asia Pacific Bone Marrow Transplantation Market By Indication, 2020-2030, USD (Million)
  • TABLE 9 Latin America Bone Marrow Transplantation Market By Type, 2020-2030, USD (Million)
  • TABLE 10 Latin America Bone Marrow Transplantation Market By Indication, 2020-2030, USD (Million)
  • TABLE 11 Middle East and Africa Bone Marrow Transplantation Market By Type, 2020-2030, USD (Million)
  • TABLE 12 Middle East and Africa Bone Marrow Transplantation Market By Indication, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Bone Marrow Transplantation Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Bone Marrow Transplantation Market: Quality Assurance
  • FIG. 5 Global Bone Marrow Transplantation Market, By Type, 2021
  • FIG. 6 Global Bone Marrow Transplantation Market, By Indication, 2021
  • FIG. 7 Global Bone Marrow Transplantation Market, By Geography, 2021
  • FIG. 8 Global Bone Marrow Transplantation Market, By Type, 2021 Vs 2030, %
  • FIG. 9 Global Bone Marrow Transplantation Market, By Indication, 2021 Vs 2030, %
  • FIG. 10 U.S. Bone Marrow Transplantation Market (US$ Million), 2020 - 2030
  • FIG. 11 Canada Bone Marrow Transplantation Market (US$ Million), 2020 - 2030
  • FIG. 12 Rest of North America Bone Marrow Transplantation Market (US$ Million), 2020 - 2030
  • FIG. 13 UK Bone Marrow Transplantation Market (US$ Million), 2020 - 2030
  • FIG. 14 Germany Bone Marrow Transplantation Market (US$ Million), 2020 - 2030
  • FIG. 15 Spain Bone Marrow Transplantation Market (US$ Million), 2020 - 2030
  • FIG. 16 Italy Bone Marrow Transplantation Market (US$ Million), 2020 - 2030
  • FIG. 17 France Bone Marrow Transplantation Market (US$ Million), 2020 - 2030
  • FIG. 18 Rest of Europe Bone Marrow Transplantation Market (US$ Million), 2020 - 2030
  • FIG. 19 China Bone Marrow Transplantation Market (US$ Million), 2020 - 2030
  • FIG. 20 Japan Bone Marrow Transplantation Market (US$ Million), 2020 - 2030
  • FIG. 21 India Bone Marrow Transplantation Market (US$ Million), 2020 - 2030
  • FIG. 22 Australia Bone Marrow Transplantation Market (US$ Million), 2020 - 2030
  • FIG. 23 South Korea Bone Marrow Transplantation Market (US$ Million), 2020 - 2030
  • FIG. 24 Rest of Asia Bone Marrow Transplantation Market (US$ Million), 2020 - 2030
  • FIG. 25 Brazil Bone Marrow Transplantation Market (US$ Million), 2020 - 2030
  • FIG. 26 Mexico Bone Marrow Transplantation Market (US$ Million), 2020 - 2030
  • FIG. 27 Rest of Latin America Bone Marrow Transplantation Market (US$ Million), 2020 - 2030
  • FIG. 28 GCC Bone Marrow Transplantation Market (US$ Million), 2020 - 2030
  • FIG. 29 Africa Bone Marrow Transplantation Market (US$ Million), 2020 - 2030
  • FIG. 30 Rest of Middle East and Africa Bone Marrow Transplantation Market (US$ Million), 2020 - 2030
目次
Product Code: 138669-08-22

Industry Outlook

The bone marrow transplantation market is set growth at a compound annual growth rate (CAGR) of 5.9% during the forecast period from 2022 to 2030. According to the research findings provided by Bristol-Myers Squibb Company, by 2040 there will be 1.85 million new cases of blood cancer will be reported worldwide.

Lower risk of disease recurrence and significant rise in the number of healthy donors drive the allogeneic bone marrow transplant market growth

Allogeneic bone marrow transplant are currently dominating the type segment for bone marrow transplantation market. The graft is free from contaminating tumor cells, the immunocompetent cells derived from healthy donor may produce an immune graft versus malignancy effect. Significant rise in the number of healthy donors and lower risk of disease recurrence together drive the allogeneic bone marrow transplant market. Autologous bone marrow transplant will be capturing the market in the near future owing to increasing number of stem cells banks which store healthy cells from the patients and, after conditioning treatment are introduced in the patient to produce healthy blood cells.

Significant rise in the new cases of Hodgkin lymphoma patients and better survival rates post bone marrow transplantation drive the lymphoma indication market growth

Lymphoma is currently reigning the indication segment for bone marrow transplantation market. It is of 2 types Hodgkin lymphoma and Non-Hodgkin lymphoma. National Cancer Institute (NCI) has reported 83,180 new cases of lymphoma in 2022. Significant rise in lymphoma patients and better survival rates post bone marrow transplantation drive the lymphoma indication market growth. Leukemia is the abnormal production of white blood cells in the bone marrow, National Cancer Institute (NCI) has reported 60,300 new cases of leukemia in 2022.

Rising prevalence of chronic lymphocytic leukemia and presence of sophisticated healthcare infrastructure drive the market growth in North America

In the present scenario North America with a revenue share of 38% is the clear leader in bone marrow transplantation market. The chief parameters contributing towards its market success are rising prevalence of chronic lymphocytic leukemia. According to American Cancer Society (ACS) research findings in 2020, it is estimated that approximately 20,720 new cases of chronic lymphocytic leukemia will be reported in North America. The prevalence rate is slightly more in men in comparison to women. Presence of sophisticated healthcare infrastructure further consolidates the market growth in North America region. Europe is in second position accounting for 32% market share owing to increasing number of patients suffering with multiple myeloma. As per the latest report provided by Myeloma Patients Europe (MPE) by 2025 the number of patients suffering with multiple myeloma will be around 46,000. Domicile of major players such as Lonza Group Ltd., Merck Millipore Corporation and PromoCell GmbH further bolster the market growth in Europe. Currently Asia Pacific holds 20% market share on account of proactive government policies to curb mortality rate associated with blood cancer and technological advancement in the bone marrow transplantation technique.

Biotechnology firms actively engaged in bone marrow transplantation procedures are: AllCells LLC., Conversant Bio., Cellular Dynamics International, Gamida Cell Ltd., Hemacare Corporation, Lonza Group Ltd., Merck Millipore Corporation, Mesoblast Ltd., PromoCell GmbH and STEMCELL Technologies.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Bone Marrow Transplantation market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Bone Marrow Transplantation market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Type

  • Allogeneic Bone Marrow Transplant
  • Autologous Bone Marrow Transplant

Indication

  • Leukemia
  • Lymphoma
  • Myeloma
  • Others

Region Segment (2020-2030; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

  • Pre COVID-19 situation
  • Post COVID-19 situation

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Bone Marrow Transplantation market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Bone Marrow Transplantation market?
  • Which is the largest regional market for Bone Marrow Transplantation market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Bone Marrow Transplantation market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Bone Marrow Transplantation market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Bone Marrow Transplantation Market
  • 2.2. Global Bone Marrow Transplantation Market, By Type, 2021 (US$ Million)
  • 2.3. Global Bone Marrow Transplantation Market, By Indication, 2021 (US$ Million)
  • 2.4. Global Bone Marrow Transplantation Market, By Geography, 2021 (US$ Million)
  • 2.5. Impact of Covid 19
  • 2.6. Attractive Investment Proposition by Geography, 2021
  • 2.7. Competitive Analysis
    • 2.7.1. Market Positioning of Key Bone Marrow Transplantation Market Vendors
    • 2.7.2. Strategies Adopted by Bone Marrow Transplantation Market Vendors
    • 2.7.3. Key Industry Strategies

3. Bone Marrow Transplantation Market: Business Outlook & Market Dynamics

  • 3.1. Introduction
  • 3.2. Global Bone Marrow Transplantation Market Value, 2020 - 2030, (US$ Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers
    • 3.3.2. Market Restraints
    • 3.3.3. Key Challenges
    • 3.3.4. Key Opportunities
  • 3.4. Impact Analysis of Drivers and Restraints
  • 3.5. See-Saw Analysis
  • 3.6. Porter's Five Force Model
    • 3.6.1. Supplier Power
    • 3.6.2. Buyer Power
    • 3.6.3. Threat Of Substitutes
    • 3.6.4. Threat Of New Entrants
    • 3.6.5. Competitive Rivalry
  • 3.7. PESTEL Analysis
    • 3.7.1. Political Landscape
    • 3.7.2. Economic Landscape
    • 3.7.3. Technology Landscape
    • 3.7.4. Legal Landscape
    • 3.7.5. Social Landscape

4. Bone Marrow Transplantation Market: By Type, 2020-2030, USD (Million)

  • 4.1. Market Overview
  • 4.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 4.3. Market Segmentation
    • 4.3.1. Allogeneic Bone Marrow Transplant
    • 4.3.2. Autologous Bone Marrow Transplant

5. Bone Marrow Transplantation Market: By Indication, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Leukemia
    • 5.3.2. Lymphoma
    • 5.3.3. Myeloma
    • 5.3.4. Others

6. North America Bone Marrow Transplantation Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Bone Marrow Transplantation Market: By Type, 2020-2030, USD (Million)
  • 6.3. Bone Marrow Transplantation Market: By Indication, 2020-2030, USD (Million)
  • 6.4.Bone Marrow Transplantation Market: By Region, 2020-2030, USD (Million)
    • 6.4.1.North America
      • 6.4.1.1. U.S.
      • 6.4.1.2. Canada
      • 6.4.1.3. Rest of North America

7. UK and European Union Bone Marrow Transplantation Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Bone Marrow Transplantation Market: By Type, 2020-2030, USD (Million)
  • 7.3. Bone Marrow Transplantation Market: By Indication, 2020-2030, USD (Million)
  • 7.4.Bone Marrow Transplantation Market: By Region, 2020-2030, USD (Million)
    • 7.4.1.UK and European Union
      • 7.4.1.1. UK
      • 7.4.1.2. Germany
      • 7.4.1.3. Spain
      • 7.4.1.4. Italy
      • 7.4.1.5. France
      • 7.4.1.6. Rest of Europe

8. Asia Pacific Bone Marrow Transplantation Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Bone Marrow Transplantation Market: By Type, 2020-2030, USD (Million)
  • 8.3. Bone Marrow Transplantation Market: By Indication, 2020-2030, USD (Million)
  • 8.4.Bone Marrow Transplantation Market: By Region, 2020-2030, USD (Million)
    • 8.4.1.Asia Pacific
      • 8.4.1.1. China
      • 8.4.1.2. Japan
      • 8.4.1.3. India
      • 8.4.1.4. Australia
      • 8.4.1.5. South Korea
      • 8.4.1.6. Rest of Asia Pacific

9. Latin America Bone Marrow Transplantation Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Bone Marrow Transplantation Market: By Type, 2020-2030, USD (Million)
  • 9.3. Bone Marrow Transplantation Market: By Indication, 2020-2030, USD (Million)
  • 9.4.Bone Marrow Transplantation Market: By Region, 2020-2030, USD (Million)
    • 9.4.1.Latin America
      • 9.4.1.1. Brazil
      • 9.4.1.2. Mexico
      • 9.4.1.3. Rest of Latin America

10. Middle East and Africa Bone Marrow Transplantation Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Bone Marrow Transplantation Market: By Type, 2020-2030, USD (Million)
  • 10.3. Bone Marrow Transplantation Market: By Indication, 2020-2030, USD (Million)
  • 10.4.Bone Marrow Transplantation Market: By Region, 2020-2030, USD (Million)
    • 10.4.1.Middle East and Africa
      • 10.4.1.1. GCC
      • 10.4.1.2. Africa
      • 10.4.1.3. Rest of Middle East and Africa

11. Company Profile

  • 11.1. AllCells LLC
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Initiatives
  • 11.2. Conversant Bio
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Initiatives
  • 11.3. Cellular Dynamics International
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Initiatives
  • 11.4. Gamida Cell Ltd.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Initiatives
  • 11.5. Hemacare Corporation
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Initiatives
  • 11.6. Lonza Group Ltd.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Initiatives
  • 11.7. Merck Millipore Corporation
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Initiatives
  • 11.8. Mesoblast Ltd
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Initiatives
  • 11.9. PromoCell GmbH
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Initiatives
  • 11.10. STEMCELL Technologies.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Portfolio
    • 11.10.4. Strategic Initiatives